General Information
Version
6.4
Revision date
2025-10-15
Product name
Sulfaquinoxaline
CAS No.
59-40-5
REACH No
A
Emergency telephone
+(45)-6991 8573, +(45)-8212 1212
Icons in SDS
Company Information
company name
Merck Life Science ApS
e-mail address of the competent person responsible for the Safety Data Sheet
TechnicalService@merckgroup.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H302, H317, H334
Hazard statements
Code
Statements
H302
Harmful if swallowed
Section 2
SECTION 2: Hazards identification
Regulation (EC) No. 1272/2008 Classification of the substance or mixture Acute toxicity, (Category 4) H302: Harmful if swallowed Respiratory sensitisation, H334: May cause allergy or asthma Category 1) symptoms or breathing difficulties if inhaled Skin sensitisation, (Category H317: May cause an allergic skin reaction
Signal word
Danger Danger
Hazard statements
H302 Harmful if swallowed. H317 May cause an allergic skin reaction. H334 May cause allergy or asthma symptoms or breathing difficulties if inhaled. H334 May cause allergy or asthma symptoms or breathing difficulties if inhaled. H317 May cause an allergic skin reaction.
Precautionary statements
P280 Wear protective gloves. P301 + P312 + P330 IF SWALLOWED: Call a POISON CENTER/ doctor if you feel unwell. Rinse mouth. P302 + P352 IF ON SKIN: Wash with plenty of water. P280 Wear protective gloves. P302 + P352 IF ON SKIN: Wash with plenty of water.
Supplemental label elements
none Reduced Labelling (<= 125 ml) none
Other hazards
This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher
2.1 Classification of the substance or mixture
Acute toxicity, (Category 4) H302: Harmful if swallowed. Respiratory sensitisation, H334: May cause allergy or asthma (Category 1) symptoms or breathing difficulties if inhaled. Skin sensitisation, (Category 1) H317: May cause an allergic skin reaction.
